Antioxidants other than vitamin C may be detected by glucose meters: Immediate relevance for patients with disorders targeted by antioxidant therapies.

Antioxidant COVID-19 Cysteine Dihydrolipoate Dithiothreitol Falsely-elevated glycemia Glucose meter Glutathione Glycemic control Glycemic mismanagement Hypoglycemic drug overdoses N-acetylcysteine Parkes’ error grid analysis Points-of-care Vitamin-C

Journal

Clinical biochemistry
ISSN: 1873-2933
Titre abrégé: Clin Biochem
Pays: United States
ID NLM: 0133660

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 22 10 2020
revised: 11 03 2021
accepted: 13 03 2021
pubmed: 27 3 2021
medline: 25 5 2021
entrez: 26 3 2021
Statut: ppublish

Résumé

Owing to their ease of use, glucose meters are frequently used in research and medicine. However, little is known of whether other non-glucose molecules, besides vitamin C, interfere with glucometry. Therefore, we sought to determine whether other antioxidants might behave like vitamin C in causing falsely elevated blood glucose levels, potentially exposing patients to glycemic mismanagement by being administered harmful doses of glucose-lowering drugs. To determine whether various antioxidants can be detected by seven commercial glucose meters, human blood samples were spiked with various antioxidants ex vivo and their effect on the glucose results were assessed by Parkes error grid analysis. Several of the glucose meters demonstrated a positive bias in the glucose measurement of blood samples spiked with vitamin C, N-acetylcysteine, and glutathione. With the most interference-sensitive glucose meter, non-blood solutions of 1 mmol/L N-acetylcysteine, glutathione, cysteine, vitamin C, dihydrolipoate, and dithiothreitol mimicked the results seen on that glucose meter for 0.7, 1.0, 1.2, 2.6, 3.7 and 5.5 mmol/L glucose solutions, respectively. Glucose meter users should be alerted that some of these devices might produce spurious glucose results not only in patients on vitamin C therapy but also in those being administered other antioxidants. As discussed herein, the clinical relevance of the data is immediate in view of the current use of antioxidant therapies for disorders such as the metabolic syndrome, diabetes, cardiovascular diseases, and coronavirus disease 2019.

Identifiants

pubmed: 33766514
pii: S0009-9120(21)00076-X
doi: 10.1016/j.clinbiochem.2021.03.007
pii:
doi:

Substances chimiques

Antioxidants 0
Blood Glucose 0
Glutathione GAN16C9B8O
Ascorbic Acid PQ6CK8PD0R
Acetylcysteine WYQ7N0BPYC

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

71-76

Informations de copyright

Copyright © 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Auteurs

Guillaume Grzych (G)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France; CHU Lille, Service d'Hormonologie, Métabolisme, Nutrition, Oncologie, F-59000 Lille, France.

Jean-David Pekar (JD)

CHU Lille, Biochemistry Emergency, F-59000 Lille, France; CHU Lille, Service de Biochimie Automatisée Protéines, F-59000 Lille, France.

Marie Joncquel Chevalier-Curt (MJ)

CHU Lille, Service d'Hormonologie, Métabolisme, Nutrition, Oncologie, F-59000 Lille, France.

Raphaël Decoin (R)

CHU Lille, Service d'Hormonologie, Métabolisme, Nutrition, Oncologie, F-59000 Lille, France.

Pauline Vergriete (P)

CHU Lille, Service de Biochimie Automatisée Protéines, F-59000 Lille, France.

Héloïse Henry (H)

Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France.

Pascal Odou (P)

Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France.

Patrice Maboudou (P)

CHU Lille, Biochemistry Emergency, F-59000 Lille, France; CHU Lille, Service de Biochimie Automatisée Protéines, F-59000 Lille, France.

Thierry Brousseau (T)

CHU Lille, Service de Biochimie Automatisée Protéines, F-59000 Lille, France.

Joseph Vamecq (J)

Inserm, EA 7364 RADEME, Univ Lille, HMNO, CBP, CHU Lille, 2, Boulevard du Prof. Jules Leclercq, 59037 Lille, France. Electronic address: joseph.vamecq@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH